AvKARE: Drug Recall
Recall #D-0224-2025 · 01/21/2025
Class II: Risk
Recall Details
- Recall Number
- D-0224-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- AvKARE
- Status
- Ongoing
- Date Initiated
- 01/21/2025
- Location
- Pulaski, TN, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 341 cartons
Reason for Recall
Out of Specification for Dissolution
Product Description
Irbesartan Tablets USP, 300 mg, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 50268-442-15
Distribution Pattern
Nationwide in the USA
Other Recalls by AvKARE
- Class II: Risk 12/31/2025
- Class II: Risk 09/02/2025
- Class II: Risk 08/25/2025
- Class II: Risk 08/25/2025
- Class III: Low Risk 06/26/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.